Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease metabolic syndrome x
Symptom C0015695|fatty liver
Sentences 45
PubMedID- 20385429 Re: soft drink consumption is associated with fatty liver disease independent of metabolic syndrome.
PubMedID- 24793377 In conclusion, in contrast to bpa, bps does not appear to induce the metabolic syndrome that may lead to non-alcoholic fatty liver disease (nafld), in vitro.
PubMedID- 25988570 Associations between dietary intake and the presence of the metabolic syndrome in patients with non-alcoholic fatty liver disease.
PubMedID- 22037024 Background & aims: despite major public health concern, therapy for non-alcoholic fatty liver, the liver manifestation of the metabolic syndrome often associated with insulin resistance (ir), remains elusive.
PubMedID- 24665369 found that serum zag concentrations were the only independent predictor of the number of metabolic syndrome components in patients with nonalcoholic fatty liver disease (nafld) after stepwise linear regression analysis.
PubMedID- 24765691 An association of non-alcoholic fatty liver disease with insulin resistant metabolic syndrome and hypothyroidism has been suggested.
PubMedID- 22813407 Association of nonalcoholic fatty liver disease with metabolic syndrome in indian population.
PubMedID- 24447068 Evidence of fatty liver was associated with metabolic syndrome (p=0.03) and insulin resistance (p=0.05).
PubMedID- 21212755 Nonalcoholic fatty liver disease is associated with the metabolic syndrome.
PubMedID- 19880582 Accumulating trans-sectional evidence suggests that the presence of multiple metabolic disorders, including obesity, diabetes, dyslipidemia, hypertension, and ultimately metabolic syndrome, are associated with nonalcoholic fatty liver disease (nafld) (1).
PubMedID- 25911912 The aim of the study was to evaluate the main features of the gastrointestinal myoelectrical activity (gi mea) in patients with nonalcoholic fatty liver disease (nafld) associated with metabolic syndrome (ms).
PubMedID- 24991603 This study aimed to find effect of salsalate on treatment of steatohepatitis and correlation of fatty liver with metabolic syndrome in the setting of impaired glucose metabolism.
PubMedID- 20645852 The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome.
PubMedID- 23032980 Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in korean adults.
PubMedID- 25031864 Among the criteria of metabolic syndrome in children with fatty liver, increased waist circumference, hypertriglyceridemia, high fasting blood sugar and high systolic blood pressure were more prevalent, respectively.
PubMedID- 21387764 Non-alcoholic fatty liver disease (nafld) in patients with metabolic syndrome and type 2 diabetes mellitus.
PubMedID- 24613289 There are distinct ethnic variations in the prevalence of fatty liver even in patients with the metabolic syndrome or obesity, suggesting that genetic factors may play a substantial role in the phenotypic expression of fatty liver.
PubMedID- 24665862 Management of fatty liver disease with the metabolic syndrome.
PubMedID- 24044566 Serum adiponectin, leptin, resistin and rbp4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease.
PubMedID- 25576388 Background: metabolic syndrome (ms) is associated with fatty liver (fl) disease.
PubMedID- 26399788 Nonalcoholic fatty liver disease is associated with metabolic syndrome and has the unique characteristic of excess lipid accumulation in liver.
PubMedID- 25739820 Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.
PubMedID- 24933975 Efficiency of ursodeoxycholic acid therapy in non-alcoholic fatty liver disease associated with metabolic syndrome.
PubMedID- 26120587 Nonalcoholic fatty liver disease relationship with metabolic syndrome in class iii obesity individuals.
PubMedID- 24816529 In particular, an insufficient e2 signaling in the erko and arko null mice models results in a metabolic syndrome-like phenotype with fatty liver due to a disruption in β-oxidation and increased lipogenesis, a phenotype that is reversed by physiological doses of e2.
PubMedID- 25738756 Moreover, metabolic syndrome is intricately associated with non-alcoholic fatty liver disease 2.
PubMedID- 23897104 Background: the association of plasma cardiovascular risk markers and metabolic syndrome (mets) with non-alcoholic fatty liver disease (nafld) has not been well defined.
PubMedID- 24850609 Effect of gene polymorphism of ppargamma2 regulatory proteins on the metabolic syndrome in children with nonalcoholic fatty liver disease and obesity.
PubMedID- 23238900 Conclusion: our fatty liver-predicting index consisted of the components of metabolic syndrome (mets) and alt, thus indicating a close relationship of fatty liver and mets.
PubMedID- 24167361 Mild increases in serum liver enzyme levels within the normal range are used as markers of fatty liver in patients with the metabolic syndrome .
PubMedID- 22292039 In addition, elevated plasma ffa is a risk factor for metabolic syndrome, which can lead to hyperlipidemia, fatty liver and insulin resistance .
PubMedID- 25661453 We aimed to determine the association between the quantity of liver fat and the presence of the metabolic syndrome in patients with biopsy-proven nonalcoholic fatty liver disease (nafld), independent of nonalcoholic steatohepatitis (nash).
PubMedID- 25960770 A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with non-alcoholic fatty liver disease.
PubMedID- 22546752 Gamma-glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome.
PubMedID- 22001208 fatty liver is strongly associated with metabolic syndrome.
PubMedID- 22808787 The aim of review: to verify the role of nutrition in development of nonalcoholic fatty liver disease in patients with metabolic syndrome.
PubMedID- 24834224 The mean body mass index of the 22 cases was 31.18 +/-5.7 and non-alcoholic fatty liver disease was associated with the metabolic syndrome in these subjects.
PubMedID- 24280560 Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction.
PubMedID- 21845221 For instance, hypoestrogenism in male rats and men is associated with fatty liver and features of the metabolic syndrome .
PubMedID- 20719718 Role of fatty liver in metabolic syndrome.
PubMedID- 23842720 Non-alcoholic steatohepatitis (nash) is the progressive phenotype of non-alcoholic fatty liver disease associated with the metabolic syndrome.
PubMedID- 21760736 Our results suggest that biof1b golden syrian hamsters are a potential model for diet-induced metabolic syndrome with associated non-alcoholic fatty liver disease.
PubMedID- 25430922 A novel animal model of metabolic syndrome with non-alcoholic fatty liver disease and skin inflammation.
PubMedID- 23974980 A similar sensitization was reported by his group for high levels of circulating fatty acids during the metabolic syndrome (obesity, diabetes), leading to a non-alcoholic fatty liver injury and hepatocyte cell death (malhi et al.
PubMedID- 21040936 The metabolic syndrome is associated with nonalcoholic fatty liver disease (nafld) as well as with insulin resistance, inflammatory adipokines, endothelial dysfunction, and higher plasma levels of nonesterified fatty acids (nefa), all of which may also affect the development of nafld.

Page: 1